Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1989-03-17
1992-05-12
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
A61K 3766
Patent
active
051126052
ABSTRACT:
Methods for the treatment of allergic reactions are provided, wherein a pharmaceutically effective dose of gamma interferon is administered to a patient within a predetermined temporal period prior to or following exposure to an allergen.
REFERENCES:
patent: 4762791 (1988-08-01), Goeddel et al.
F. D. Finkelman et al., J. Immunol 141: 2335 (1988); "IL-4 is Required to Generate and Sustain In Vivo IgE Responses".
F. D. Finkelman et al., J. Immunol 137:3878 (1986); "Production of BSF-1 During an In Vivo, T-Dependent Immune Response".
I. M. Katona et al., J. Immunol 140:3206 (1988); "The Role of L3T4+ T Cells in the IgE Response and Immunity to Nippostronglyus brasiliensis".
F. D. Finkelman et al., J. Immunol 142:403 (1989); "T Help Requirements for the Generation of an In Vivo IgE Response: A Late Acting Form of T Cell Help Other Than IL-4 is Required for IgE But Not for IgGl Production".
Coffmen et al., J. Immunol. 136:949 (1986); "A T Cell Activity That Enhances Polyclonal IgE Production and Its Inhibition by Interferon-.gamma.".
Snapper et al., Science 236:944 (1987); "Interferon-.gamma. and B Cell Stimulatory Factor-1 Reciprocally Regulate Ig Isotype Production".
Coffman, et al., Immune Regulation by Characterized Polypeptides, Alan R. Liss, Inc., 523-532 (1987).
T. DeFrance et al., J. Exp. med. 165:1459 (1987); "Human Recombinant Interleukin 4 Induces Fce Receptors (CD23) on Normal Human B Lymphocytes".
S. A. Hudak et al., PNAS 84:4606 (1987); "Murine B-Cell Stimulatory Factor 1 (Interleukin 4) Increases Expression of the Fc Receptor for IgE on Mouse B Cells".
F. D. Finkelman et al., J. Immunol. 140:1022 (1988); "IFN-.gamma. Regulates the Isetypes of Ig Secreted During In Vivo Humoral Immune Responses".
Boguniewicz et al., J. Allergy and Clin. Immunol 83:307 (100), "In Vivo Treatment of Atopic Dermatitis (AD) with Recombinant Gamma Interferon (rIFN-.gamma.)" (1989).
Li et al., J. Allergy and Clin. Immunol. 83:307 (543) (1989); "Recombinant Interferon Gamma in the Treatment of Allergic Rhinitis".
J. M. Parkin et al., Br. Med. J. [Clin. Res.] 294:1185 (1987); "Atopic Manifestations in the Acquired Immune Deficiency Syndrome: Response to Recombinant Interferon Gamma".
Adler Carolyn R.
Dreger Ginger R.
Genentech Inc.
Koh Choon P.
Schain Howard E.
LandOfFree
Temporal gamma-interferon administration for allergies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Temporal gamma-interferon administration for allergies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Temporal gamma-interferon administration for allergies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2425717